vs
Flora Growth Corp.（FLGC）与Cellyan Biotechnology Co., Ltd（HKPD）财务数据对比。点击上方公司名可切换其他公司
Flora Growth Corp是一家全球化大麻与健康产品企业，主营优质大麻及大麻衍生物的种植、加工与分销，产品涵盖大麻基快消品、护肤系列及药用制剂，主要服务拉美、北美及欧洲的娱乐与医用大麻消费市场。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
FLGC
HKPD
| Q4 25 | $-654.0K | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.8M | — | ||
| Q1 25 | $11.8M | — | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $15.7M | — |
净利润FLGCHKPD
| Q4 25 | $-109.9M | — | ||
| Q3 25 | $-6.7M | — | ||
| Q2 25 | $-2.4M | — | ||
| Q1 25 | $-758.0K | — | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-3.8M | — | ||
| Q2 24 | $-2.6M | — |
毛利率FLGCHKPD
| Q4 25 | 673.4% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 24.5% | — | ||
| Q4 24 | 104.6% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 20.2% | — |
营业利润率FLGCHKPD
| Q4 25 | 22606.0% | — | ||
| Q3 25 | -33.5% | — | ||
| Q2 25 | -17.3% | — | ||
| Q1 25 | -8.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -29.2% | — | ||
| Q2 24 | -22.6% | — |
净利率FLGCHKPD
| Q4 25 | 16804.7% | — | ||
| Q3 25 | -68.3% | — | ||
| Q2 25 | -16.3% | — | ||
| Q1 25 | -6.4% | — | ||
| Q4 24 | 120.5% | — | ||
| Q3 24 | -52.1% | — | ||
| Q2 24 | -16.8% | — |
每股收益（稀释后）FLGCHKPD
| Q4 25 | $-34.29 | — | ||
| Q3 25 | $-9.05 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-38.40 | — | ||
| Q3 24 | $-11.03 | — | ||
| Q2 24 | $-0.21 | — |
